SurGenTec Releases TiLink-Insite Sterile SI Joint Fusion Kit

SurGenTec has launched its new TiLink-Insite sacroiliac (SI) system, which is available in a sterile, surgery-ready kit.

The Insite kit boasts a set of single-use, sterile instruments paired with a 3D-printed titanium implant. The kit was engineered to reduce infection risk and support a minimally invasive approach.

The implant leverages proprietary nano-surface technology to stimulate bone-on-implant growth and promote lasting biologic fixation. Its large central graft window allows significant graft volume for osseointegration across the ilium and sacrum. An integrate trellis architecture provides structural strength and open porosity to support bone in-growth, as well.

Threaded insertion removes the need for malleting, which minimizes surgical trauma and allows smooth, controlled placement through a single incision about the size of a quarter. Insite offers a cost-effective, surgery-ready option for SI joint dysfunction, SurGenTec said.

The company plans to make its whole SI joint fusion portfolio available in sterile kit formats by year’s end. Insite grows its expanding SI joint fusion portfolio, which includes the TiLink-P posterior SI fusion device and TiLink-L implant for an oblique or lateral approach.

“Insite has been engineered with both patients and physicians in mind,” said Travis Greenhalgh, CEO of SurGenTec. “We’re offering a system that not only simplifies the procedure with a complete, sterile, single-use kit but also provides the greatest opportunity for long-term fusion. The strong feedback we’ve received from early adopters validates our approach and furthers our mission to transform care in SI joint fusion.”

Earlier this year, the company received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoFlo HydroFiber bone graft technology.